Suppr超能文献

基质金属蛋白酶在肿瘤血管生成中的多效性作用:对比、重叠和补偿性功能

Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.

作者信息

Deryugina Elena I, Quigley James P

机构信息

The Scripps Research Institute, La Jolla, CA, USA.

出版信息

Biochim Biophys Acta. 2010 Jan;1803(1):103-20. doi: 10.1016/j.bbamcr.2009.09.017. Epub 2009 Oct 2.

Abstract

A number of extensive reviews are available discussing the roles of MMPs in various aspects of cancer progression from benign tumor formation to overt cancer present with deadly metastases. This review will focus specifically on the evidence functionally linking the MMPs and tumor-induced angiogenesis in various in vivo models. Emphasis has been placed on the cellular origin of the MMPs in tumor tissue, the requirement of proMMP activation and the resulting proteolytic activity for the induction and progression of tumor angiogenesis, and the pleiotropic roles for some of the MMPs. The functional mechanisms of the angiogenic MMPs are discussed as well as their catalytic detection in complex biological systems. In addition, the contribution of active MMPs to metastatic spread and establishment of secondary metastasis will be discussed in view of the findings indicating that MMPs are involved in the preparation of pre-metastatic niches. Finally, the most recent evidence, indicating the pro-metastatic consequences of anti-angiogenic therapies employing MMP inhibitors will be presented as examples highlighting possible outcomes of interfering with the pleiotropic nature of the MMP functionality.

摘要

已有多篇全面综述探讨了基质金属蛋白酶(MMPs)在癌症进展各个方面的作用,从良性肿瘤形成到伴有致命转移的明显癌症。本综述将特别关注在各种体内模型中,将MMPs与肿瘤诱导的血管生成在功能上联系起来的证据。重点在于肿瘤组织中MMPs的细胞来源、前MMP激活的必要性以及由此产生的蛋白水解活性对肿瘤血管生成诱导和进展的作用,以及某些MMPs的多效性作用。讨论了血管生成性MMPs的功能机制及其在复杂生物系统中的催化检测。此外,鉴于有研究表明MMPs参与了前转移微环境的形成,将讨论活性MMPs对转移扩散和继发性转移形成的作用。最后,将展示最新证据,即使用MMP抑制剂的抗血管生成疗法的促转移后果,以此为例突出干扰MMP功能多效性可能产生的结果。

相似文献

1
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.
Biochim Biophys Acta. 2010 Jan;1803(1):103-20. doi: 10.1016/j.bbamcr.2009.09.017. Epub 2009 Oct 2.
2
3
Matrix metalloproteinases and tumor metastasis.
Cancer Metastasis Rev. 2006 Mar;25(1):9-34. doi: 10.1007/s10555-006-7886-9.
4
Roles of matrix metalloproteinases in tumor metastasis and angiogenesis.
J Biochem Mol Biol. 2003 Jan 31;36(1):128-37. doi: 10.5483/bmbrep.2003.36.1.128.
5
Matrix metalloproteinases: protective roles in cancer.
J Cell Mol Med. 2011 Jun;15(6):1254-65. doi: 10.1111/j.1582-4934.2011.01302.x.
6
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.
Pathol Oncol Res. 2001;7(1):14-23. doi: 10.1007/BF03032599.
7
Matrix metalloproteinase inhibitors.
Invest New Drugs. 1997;15(1):61-75. doi: 10.1023/a:1005722729132.
8
Matrix metalloproteinases: changing roles in tumor progression and metastasis.
Am J Pathol. 2012 Dec;181(6):1895-9. doi: 10.1016/j.ajpath.2012.08.044. Epub 2012 Oct 12.
9
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Oncogene. 2000 Dec 27;19(56):6642-50. doi: 10.1038/sj.onc.1204097.

引用本文的文献

4
Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer.
Biol Direct. 2025 Jan 16;20(1):8. doi: 10.1186/s13062-025-00599-x.
5
Immune Cell Migration to Cancer.
Cells. 2024 May 16;13(10):844. doi: 10.3390/cells13100844.
6
Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer.
Bioact Mater. 2023 Nov 15;33:174-222. doi: 10.1016/j.bioactmat.2023.10.004. eCollection 2024 Mar.
7
Molecular and phenotypic distinctions of macrophages in tolerant and susceptible to hypoxia rats.
PeerJ. 2023 Oct 10;11:e16052. doi: 10.7717/peerj.16052. eCollection 2023.
8
Association of gene polymorphisms with breast cancer risk: A narrative review.
Health Sci Rep. 2023 Oct 13;6(10):e1607. doi: 10.1002/hsr2.1607. eCollection 2023 Oct.
9
A detailed insight of the tumor targeting using nanocarrier drug delivery system.
Drug Deliv. 2023 Dec;30(1):2183815. doi: 10.1080/10717544.2023.2183815.
10
Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody.
Antibodies (Basel). 2023 Jan 18;12(1):9. doi: 10.3390/antib12010009.

本文引用的文献

1
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.
J Leukoc Biol. 2009 Nov;86(5):1065-73. doi: 10.1189/jlb.0609385. Epub 2009 Sep 9.
2
Matrix metalloproteinase proteomics: substrates, targets, and therapy.
Curr Opin Cell Biol. 2009 Oct;21(5):645-53. doi: 10.1016/j.ceb.2009.06.006. Epub 2009 Jul 16.
4
Neutrophils: key mediators of tumour angiogenesis.
Int J Exp Pathol. 2009 Jun;90(3):222-31. doi: 10.1111/j.1365-2613.2009.00641.x.
5
Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited.
J Cell Biol. 2009 Apr 6;185(1):11-9. doi: 10.1083/jcb.200807195. Epub 2009 Mar 30.
6
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.
Cancer Cell. 2009 Mar 3;15(3):232-9. doi: 10.1016/j.ccr.2009.01.021.
8
Cellular and molecular mechanisms of vascular lumen formation.
Dev Cell. 2009 Feb;16(2):222-31. doi: 10.1016/j.devcel.2009.01.013.
9
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.
Cell. 2009 Mar 6;136(5):839-851. doi: 10.1016/j.cell.2009.01.020. Epub 2009 Feb 12.
10
Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.
Cancer Res. 2009 Feb 15;69(4):1517-26. doi: 10.1158/0008-5472.CAN-08-3255. Epub 2009 Feb 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验